A variety of cancer-related signaling pathways were revealed to be associated with PTEN loss, namely, ERBB, VEGF, p53, epidermal growth factor receptor (EGFR), MAPK, reactive oxygen species, and Ras. The gene discussed is EGFR; the disease is cancer.